Telehealth Evidence

Telehealth for Acne and Eczema: What the Dermatology Evidence Shows

A review of published clinical studies on teledermatology for acne and eczema — and what the outcomes data means if you're considering a virtual visit for your skin.

Key Takeaways

  • A 21-study review found teledermatology produces comparable acne outcomes to in-person visits, with an 87.94% reduction in acne grading scores.[1]
  • 71.8% of acne patients said they would choose video visits for future dermatology care.[1]
  • Eczema patients using digital tools saw a 44% drop in SCORAD severity scores and a 31% lower relapse rate compared to standard care.[5][6]
  • Telemedicine achieved 84.4% diagnostic accuracy for eczema, and 72% of cases were managed without an in-person specialist visit.[7]
  • Average wait times dropped from 13.7 weeks to 4.6 weeks for acne and from 6.7 months to 1.5 months for eczema — a 66–78% reduction.[1][7]
Teledermatology consultation showing a physician evaluating skin conditions via video visit
Published evidence shows teledermatology achieves comparable outcomes to in-person visits for both acne and eczema management.

Why This Matters for Acne and Eczema Patients

Getting in to see a dermatologist takes time. In many parts of the country, the wait runs three to four months. If you have acne that's getting worse or an eczema flare that won't quit, that delay isn't just inconvenient — it lets the condition progress, sometimes to the point where treatment becomes harder.

Teledermatology has grown fast over the past several years. But growth alone doesn't tell you whether it works. The question patients ask me most often is direct: "Will I get the same quality of care through a video visit as I would sitting in a dermatology office?"

The published evidence now gives us a clear answer for acne and eczema specifically. Here's what the data shows.

The Acne Evidence

The strongest summary of acne teledermatology comes from a 2024 systematic review in the Journal of Cutaneous Medicine and Surgery, which pooled findings from 21 studies.[1] The conclusion was unambiguous: teledermatology is well-suited for acne management, with outcomes on standard grading scales that match in-person care.

The numbers are specific. Patients treated via teledermatology showed an 87.94% reduction in GAGS scores (Global Acne Grading System) — a widely used severity measure. Separate concordance research found a kappa value of 0.611 between teledermatology and face-to-face acne severity assessments, indicating good agreement, with 75.2% overall concordance.[3]

Patient satisfaction ran high. In the review, 100% of surveyed patients felt their concerns were addressed during the virtual visit. When asked about future preferences, 71.8% said they would choose video visits for ongoing dermatology care.[1] Among patients on isotretinoin — a medication that requires close monitoring — 65.2% preferred video check-ins over in-person appointments.

The access gains were substantial. Average wait times dropped from 13.7 weeks to 4.6 weeks with teledermatology.[1] That's nine fewer weeks of untreated or undertreated acne.

A 2025 study of a telemedicine acne platform treating 16,800 patients confirmed these patterns at scale, showing that a combined synchronous and asynchronous model produced outcomes comparable to in-person care with high patient engagement.[2]

One area to watch: follow-up compliance was lower in teledermatology groups (13% returned within 90 days, compared to 31% for in-person patients).[1] In my practice, I address this by scheduling the next check-in before the current visit ends. Making follow-up easy matters more than making it available.

Side-by-side comparison of telehealth dermatology visit and in-person clinic visit showing equivalent outcomes
Multiple studies confirm that virtual and in-person dermatology visits achieve equivalent therapeutic outcomes for acne.

The Eczema Evidence

Eczema — atopic dermatitis, specifically — presents differently than acne for telehealth. It flares unpredictably, often requires treatment adjustments between office visits, and responds well to patient education. All of those features make it a strong candidate for virtual care, and the studies back that up.

A 2022 digital intervention study showed a 44% reduction in SCORAD scores (from 56.1 to 31.2, p<0.001) and a 46% reduction in POEM scores (from 15.7 to 8.5, p<0.001) among patients using a telemedicine-based approach.[5] Higher treatment adherence tracked directly with larger improvements — patients who used the digital tools more got better faster.

Diagnostic accuracy is a common concern with virtual skin evaluations. A 2020 study tested this head-on: telemedicine achieved an 84.4% diagnostic match with in-person dermatology for atopic dermatitis. In that same study, 72% of cases were fully managed through primary care plus teledermatology, without requiring an in-person specialist visit.[7] Wait times fell from 6.7 months to 1.5 months — a 78% reduction.

A 2025 systematic review in Dermatologic Surgery examined multiple telemedicine studies for atopic dermatitis and found consistent decreases in both POEM and IGA severity scores across four separate trials.[4]

The most recent data comes from a 615-patient randomized controlled trial published in JMIR in January 2026.[6] Patients randomized to smartphone-based eczema education had a 12-week relapse rate of 16.6%, compared to 24.0% in the control group (relative risk 0.69, p=.02). That's a 31% lower chance of relapse. Engagement held: 58% of patients maintained regular weekly use of the digital tools throughout the study.

A separate RCT of 102 adults found that internet-delivered cognitive behavioral therapy (CBT) for atopic dermatitis led to significantly greater symptom improvement on the POEM scale (effect size d=0.75, p<.001), with benefits persisting at 12-month follow-up.[8] Eczema has a well-documented stress component, and these results suggest that virtual behavioral support can reduce flares in ways that medication alone does not.

Outcome Measure Acne (Telehealth) Eczema (Telehealth)
Clinical outcomes vs. in-person Comparable on GAGS, GAS, and TLC scales[1] 84.4% diagnostic accuracy match[7]
Symptom improvement 87.94% reduction in acne grading score[1] 44% reduction in SCORAD severity score[5]
Patient satisfaction 71.8% would choose video visits again[1] High satisfaction; 58% weekly engagement rate[6]
Wait time reduction 13.7 weeks to 4.6 weeks (66% faster)[1] 6.7 months to 1.5 months (78% faster)[7]
Key limitation Lower follow-up compliance (13% vs. 31%)[1] Relapse benefit diminished after 12 weeks[6]

What This Means for Patients

If you're dealing with acne or eczema, here's what I take from this evidence:

You don't need to wait months for a first evaluation. Teledermatology assessments agree with in-person assessments the large majority of the time. Starting treatment sooner — even by a few weeks — makes a real difference, especially for acne scarring risk and eczema flare severity.

Follow-up visits are where telehealth may add the most value. Acne treatment is iterative. Eczema management requires ongoing adjustments. Both conditions benefit from frequent, short check-ins — the kind that are easy to do over video but hard to justify as a full in-person appointment.

Digital tools between visits improve outcomes. The eczema relapse data is striking. Patients who stayed engaged with smartphone-based education between appointments did measurably better than those who relied on office visits alone. This isn't a replacement for physician care — it's a layer on top of it.

Satisfaction is high because the experience works. Patients aren't choosing video visits out of novelty. They're choosing them because the care feels thorough and the access is faster. When 71.8% of dermatology patients prefer video for future care, that's a signal worth paying attention to.

When In-Person Care Is Still Needed

Telehealth works well for acne and eczema, but it doesn't replace every dermatology visit. Here's where I still refer patients for hands-on evaluation:

Works Well Virtually

  • Mild-to-moderate acne evaluation and treatment
  • Acne medication follow-ups (including isotretinoin check-ins)
  • Eczema flare management and treatment adjustments
  • Ongoing eczema maintenance and education
  • Prescription renewals for stable skin conditions

Needs In-Person Evaluation

  • First visit for isotretinoin initiation (baseline labs, iPLEDGE enrollment)
  • Severe nodulocystic acne requiring procedural intervention
  • Suspected skin biopsy for uncertain diagnoses
  • Patch testing for contact dermatitis
  • Widespread or atypical rashes that need full-body exam
  • Eczema unresponsive to two or more treatment regimens

The best approach is usually a blend. Start with a virtual visit to get an evaluation, begin treatment, and establish a care plan. Then use follow-up video visits for monitoring and adjustments, reserving in-person appointments for the scenarios listed above. That's the model the evidence supports, and it's the one I use with my own patients.

References

  1. Barbieri CE et al. "Teledermatology and Virtual Visits for Acne Management: A Review." Journal of Cutaneous Medicine and Surgery. 2024;28(6). pmc.ncbi.nlm.nih.gov
  2. "A Telemedicine-Based Approach for Acne Management." Clinical, Cosmetic and Investigational Dermatology. 2025;18. 16,800-patient platform study. pmc.ncbi.nlm.nih.gov
  3. "Acne Severity Assessment via Teledermatology During the COVID-19 Pandemic." Journal of Clinical and Aesthetic Dermatology. 2021. Kappa 0.611, 75.2% concordance. jcadonline.com
  4. "Telemedicine in the Care of Patients with Atopic Dermatitis." Dermatologic Surgery / Liebertpub. 2025. Systematic review. liebertpub.com
  5. "Digital Intervention for Atopic Dermatitis: SCORAD and POEM Outcomes." 2022. SCORAD decreased 44%, POEM decreased 46%. pmc.ncbi.nlm.nih.gov
  6. "Smartphone-Based Eczema Education: A 615-Patient Randomized Controlled Trial." JMIR. 2026;e79559. 12-week relapse rate 16.6% vs 24.0% (RR 0.69, p=.02). jmir.org
  7. "Telemedicine Diagnostic Accuracy for Atopic Dermatitis." 2020. 84.4% diagnostic match, 72% managed without in-person specialist. Wait times reduced 78%. pmc.ncbi.nlm.nih.gov
  8. "Internet-Delivered CBT for Atopic Dermatitis: A Randomized Clinical Trial." JAMA Dermatology. 2021. 102 adults, d=0.75, benefits maintained at 12 months. jamanetwork.com
PB

Parth Bhavsar, MD

Board-Certified Family Medicine Physician

Dr. Bhavsar founded TeleDirectMD to deliver board-certified physician care through telehealth. He treats acne, eczema, and other common skin conditions via virtual visits and follows the dermatology evidence closely to ensure patients receive the same standard of care they would in a traditional office setting.